Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-03-06
2007-03-06
Mondesi, Robert B. (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C514S012200
Reexamination Certificate
active
10896455
ABSTRACT:
The present invention is directed to hemostatic devices comprising a substrate, which substrate comprises a precipitate of a protein in an amount effective to provide hemostatic properties to the substrate, or to maintain and/or improve hemostatic properties of the substrate, and to methods of making such devices, wherein the substrate comprising the precipitate of the protein is prepared by precipitation of the protein on or into the substrate upon contacting the protein with the substrate.
REFERENCES:
patent: 2605887 (1952-08-01), Duncan
patent: 3649293 (1972-03-01), Hoer et al.
patent: 4789733 (1988-12-01), Winkelman
patent: 5134229 (1992-07-01), Saferstein et al.
patent: 6121232 (2000-09-01), Nur et al.
patent: WO 92/13495 (1992-08-01), None
Merriam-Webster Online Dictionary publication, http://www.m-w.com/cgi-bin/dictionary?book=Dictionary&va=animal, Mar. 11, 2006.
Badin et al., Selective chemical precipitation of serum proteins as an inexpensive tool for health screening and diagnosis, 1978, Ricerca in Clinica e in Laboratorio, vol. 8(Suppl. 1), pp. 183-193.
Gorman Anne J.
Pendharkar Sanyog M.
Ethicon Inc.
Mondesi Robert B.
LandOfFree
Hemostatic device containing a protein precipitate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hemostatic device containing a protein precipitate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemostatic device containing a protein precipitate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3735840